Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction

First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue

Free
Message: AGORACOM Small Cap 60: Awakn LifeSciences Aims To Be Leading Company In #Psychedelics Industry Focused On Treating #Addiction

AGORACOM Small Cap 60: Awakn LifeSciences Aims To Be Leading Company In #Psychedelics Industry Focused On Treating #Addiction

posted on Feb 10, 2022 12:00PM

Share
New Message
Please login to post a reply